Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 2209007Generated: November 2, 2026

2,2'-Bipyridine → 4-(benzyloxy)-6-chloro-3-cyclopropyl-3H-imidazo[4,5-c]pyridine

https://huagongshe.com/reaction/2209007

Reaction equation

Participants

RoleNameHCIDCharge
Reactant2,2'-BipyridineHCID 1474—
ReactantSodium CarbonateHCID 10340—
ReactantBoronic AcidHCID 61668—
ReactantCyclopropylboronic acidHCID 2760897—
ReactantHCID 178477827HCID 178477827—
CatalystCupric acetateHCID 8895—
Solvent1,2-DichloroethaneHCID 11—
SolventEthyl AcetateHCID 8857—
Product4-(benzyloxy)-6-chloro-3-cyclopropyl-3H-imidazo[4,5-c]pyridineHCID 117843000—

Reaction Conditions

Temperature70 °C

Reaction Steps

In a separate flask 4-(benzyloxy)-6-chloro-3H-imidazo[4,5-c]pyridine 2.24 (502 mg, 1.93 mmol), cyclopropane boronic acid (334 mg, 3.89 mmol) and Na2CO3 (415 mg, 3.9 mmol) were taken up in 1,2-DCE (13 mL). The aforementioned catalyst mixture was then added to this mixture, washing with 4×1 mL 1,2-DCE. The resulting mixture was heated to 70° C. and was stirred open to the air. After 7 h, additional Na2CO3 (215 mg, 2.03 mmol) and boronic acid (170 mg, 2.0 mmol) were added along with a heated suspension of Cu(OAc)2 (182 mg, 1.0 mmol) and 2,2′-bipyridine (155 mg, 0.99 mmol) in 1,2-DCE (3 mL). After an additional 1.5 h, additional boronic acid (340 mg, 4.0 mmol) and Na2CO3 (415 mg, 3.9 mmol) were added and the reaction was capped and stirred overnight. After an additional 14.5 h, additional boronic acid (150 mg, 1.7 mmol) and Na2CO3 (215 mg, 2.03 mmol) were added and the mixture was stirred open to air. After an additional 1.5 h, the reaction mixture was cooled to r.t., was diluted with EtOAc (75 mL), and was filtered through Celite. The filtrate was washed with half-saturated aqueous NH4Cl (75 mL), water (50 mL), and brine (50 mL). The organic phase was dried over Na2SO4, filtered, and concentrated. Purification by silica gel chromatography (0% to 5% THF in DCM) provided 4-(benzyloxy)-6-chloro-3-cyclopropyl-3H-imidazo[4,5-c]pyridine 2.35.

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS09376441B2
Source datasetuspto-grants-2016_06
ORD IDord-c393bf07b92443a58e7fb724b84ef202
Source noteuspto-grants-2016_06